A longitudinal study of physical activity among Malaysian breast cancer survivors.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
06
2022
accepted:
07
11
2022
entrez:
21
11
2022
pubmed:
22
11
2022
medline:
24
11
2022
Statut:
epublish
Résumé
Regular physical activity (PA) after a breast cancer diagnosis is associated with reduced mortality and better quality of life. In this prospective cohort study, we aimed to explore the trends of PA among breast cancer survivors over three years and identify factors associated with low PA. Interviews on 133 breast cancer patients were conducted at baseline, one and three years after the diagnosis of breast cancer at University Malaya Medical Centre in Kuala Lumpur. Physical activity was measured by using the Global Physical Activity Questionnaire. PA was categorised as active (≥ 600 MET-min/week) and inactive (<600 MET-min/week). We used the generalised estimating equation method to examine PA levels and factors affecting PA longitudinally. The survivors' mean age was 56.89 (±10.56) years; half were Chinese (50.4%), and 70.7% were married. At baseline, 48.1% of the patients were active, but the proportion of active patients declined to 39.8% at one year and 35.3% in the third year. The mean total PA decreased significantly from 3503±6838.3 MET-min/week to 1494.0±2679.8 MET-min/week (one year) and 792.5±1364 MET-min/week (three years) (p<0.001). Three years after diagnosis (adjusted odds ratio [AOR]: 1.74, p = 0.021); Malay ethnicity (AOR: 1.86, p = 0.042) and being underweight (AOR: 3.43, p = 0.004) were significantly associated with inactivity. We demonstrated that breast cancer survivors in Malaysia had inadequate PA levels at diagnosis, which decreased over time. Thus, it is vital to communicate about the benefits of PA on cancer outcomes and continue to encourage breast cancer survivors to be physically active throughout the extended survivorship period, especially in the Malay ethnic group and underweight patients.
Identifiants
pubmed: 36409745
doi: 10.1371/journal.pone.0277982
pii: PONE-D-22-16080
pmc: PMC9678261
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0277982Informations de copyright
Copyright: © 2022 Lee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2009 Aug 13;361(7):664-73
pubmed: 19675330
Am Heart J. 2006 Apr;151(4):923-7
pubmed: 16569565
Breast Cancer Res Treat. 2011 Jul;128(1):237-42
pubmed: 21197566
Health Educ Res. 2003 Apr;18(2):156-70
pubmed: 12729175
BMJ Open. 2015 Oct 26;5(10):e008643
pubmed: 26503386
Support Care Cancer. 2016 Aug;24(8):3333-42
pubmed: 26970957
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
Psychooncology. 2022 Feb;31(2):167-175
pubmed: 34460129
BMJ Open. 2018 May 18;8(5):e020276
pubmed: 29776920
Work. 2011;38(4):337-46
pubmed: 21508523
Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11):
pubmed: 29117982
BMC Cancer. 2020 Oct 19;20(1):1013
pubmed: 33076863
Asian Pac J Cancer Prev. 2016;17(8):4083-8
pubmed: 27644665
J Clin Oncol. 2017 Nov 10;35(32):3635-3637
pubmed: 28915086
Support Care Cancer. 2019 Jan;27(1):109-122
pubmed: 30302542
Am J Transl Res. 2014 Oct 11;6(5):422-38
pubmed: 25360210
J Nurs Scholarsh. 2009 Mar;41(1):20-7
pubmed: 19335674
Int J Behav Nutr Phys Act. 2021 Apr 6;18(1):50
pubmed: 33823832
Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1324-30
pubmed: 24753546
Oncology. 2018;95(3):188-191
pubmed: 29847828
Psychooncology. 2014 Jan;23(1):27-34
pubmed: 24003002
Med Sci Sports Exerc. 2009 Apr;41(4):935-46
pubmed: 19276838
Cancer. 2003 Apr 1;97(7):1746-57
pubmed: 12655532
Cancer. 2009 Jun 15;115(12):2775-82
pubmed: 19365847
Prev Med Rep. 2016 Mar 09;3:250-6
pubmed: 27419023
Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1153-61
pubmed: 23576689
Breast. 2018 Aug;40:23-28
pubmed: 29674221
J Cancer Surviv. 2010 Jun;4(2):119-27
pubmed: 20180037
Cancer Med. 2018 Dec;7(12):6331-6339
pubmed: 30358141
BMC Public Health. 2014;14 Suppl 3:S8
pubmed: 25437351
Med J Malaysia. 2014 Aug;69 Suppl A:8-22
pubmed: 25417947
JMIR Mhealth Uhealth. 2020 Sep 21;8(9):e18867
pubmed: 32955446
Acta Oncol. 2017 Apr;56(4):618-627
pubmed: 28084890
Prev Chronic Dis. 2016 Apr 21;13:E53
pubmed: 27103263
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):430-8
pubmed: 17372237
Asian Pac J Cancer Prev. 2010;11(1):61-6
pubmed: 20593932
J Cancer Prev. 2013 Sep;18(3):193-200
pubmed: 25337546
Asia Pac J Public Health. 2015 Mar;27(2):NP184-93
pubmed: 22234832
Breast Care (Basel). 2018 Apr;13(2):93-101
pubmed: 29887785
Med Sci Sports Exerc. 2004 Sep;36(9):1484-91
pubmed: 15354027
PLoS One. 2016 Jun 22;11(6):e0157730
pubmed: 27332883
Breast Cancer Res Treat. 2009 Aug;116(3):609-16
pubmed: 18855135
Sports Med. 2007;37(11):947-60
pubmed: 17953466
Support Care Cancer. 2018 May;26(5):1617-1624
pubmed: 29209834
J Occup Rehabil. 2010 Mar;20(1):49-58
pubmed: 19902340
Breast Cancer Res Treat. 2012 Jan;131(2):679-90
pubmed: 21953007
Integr Cancer Ther. 2018 Mar;17(1):16-30
pubmed: 28008778